OriCell Therapeutics Raises Over $120 Million in Series B Fi

2022 is set to be a milestone year for OriCell who has been focusing on the field of cancer immunotherapy for more than seven years and is fully c...

Related Keywords

China , Qiming , Sichuan , Australia , Shanghai , United States , Chinese , Australian , American , Weidong Cui , Helen Yang , Australian Therapeutic Goods Administration , Technology Officer , American Society Of Clinical Oncology , Prnewswire Oricell Therapeutics Shanghai Co Ltd , National Medical Products Administration , Drug Administration , Cell Therapeutics , Qiming Venture Partners , Quan Capital , Investigational New Drug , Clinical Oncology , Only Grade , Drug Evaluation , Clinical Trials Notification , Chief Technology , Fosun Kite , Oricell Therapeutics ,